[Clinical studies with sorafenib (Nexavar) in metastatic melanoma].
Hauschild
Axel
A
Klinik für Dermatologie, Venerologie und Allergologie, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Keil, Germany. ahauschild@dermatology.uni-kiel.de
D000970:Antineoplastic Agents / Q000008:administration & dosage; D001557:Benzenesulfonates / Q000008:administration & dosage*; D002986:Clinical Trials as Topic / Q000639:trends*; D006801:Humans; D008545:Melanoma / Q000188:drug therapy* / Q000556:secondary*; D009536:Niacinamide / Q000031:analogs & derivatives; D010671:Phenylurea Compounds; D011725:Pyridines / Q000008:administration & dosage*; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D000077157:Sorafenib; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D001557:Benzenesulfonates; D010671:Phenylurea Compounds; D011725:Pyridines; D009536:Niacinamide; D000077157:Sorafenib